Physiological pharmacokinetic model for distribution and elimination of pentazocine. II. Study in rabbits and scale-up to man
- 1 March 1984
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 19 (1) , 75-88
- https://doi.org/10.1016/0378-5173(84)90134-0
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Estimation of tissue-to-plasma partition coefficients used in physiological pharmacokinetic modelsJournal of Pharmacokinetics and Biopharmaceutics, 1979
- Pharmacokinetics of pentazocine in dogs under halothane anesthesia.CHEMICAL & PHARMACEUTICAL BULLETIN, 1979
- Bioavailability and first‐pass metabolism of oral pentazocine in manClinical Pharmacology & Therapeutics, 1977
- Physiologically Based Pharmacokinetic Model for Digoxin Disposition in Dogs and Its Preliminary Application to HumansJournal of Pharmaceutical Sciences, 1977
- Pharmacokinetic Model for Simultaneous Determination of Drug Levels in Organs and TissuesJournal of Pharmaceutical Sciences, 1976
- Pentazocine binding to blood cells and plasma proteinsClinical Pharmacology & Therapeutics, 1974
- Lidocaine disposition kinetics in monkey and man; I. Prediction by a perfusion modelClinical Pharmacology & Therapeutics, 1974
- Plasma and cerebrospinal fluid concentrations of pentazocine in patients: assay by mass fragmentographyJournal of Pharmacy and Pharmacology, 1974
- Methotrexate PharmacokineticsJournal of Pharmaceutical Sciences, 1971
- Thiopental PharmacokineticsJournal of Pharmaceutical Sciences, 1968